Fang-Yu Lin

Computer ScienceMedicineEngineeringMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors”.

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Nature Communications(2021)10.1038/s41467-021-22362-2

N/A

4.1DataRank · unranked

115 citations

F. Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair +7 more

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Nature Communications(2021)10.1038/s41467-021-23082-3

N/A

0DataRank · unranked

8 citations

F. Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair +7 more

Patient-reported symptom burden and functioning in patients with advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer undergoing chemotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.183

N/A

0DataRank · unranked

3 citations

Lisa M. Hess, Fang-Yu Lin, Tsun Hsuan Chen, Elizabeth M. Gonzalez, Araceli García-González +5 more